Assistant Professor
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
Utrecht University
Utrecht, Netherlands
Currently appointed as Assistant Professor at Division of Pharmacoepidemiology and Clinical Pharmacology of Utrecht Institute for Pharmaceutical Sciences at Utrecht University, I have a strong interest in studying drugs utilisation and outcomes using real-world data from electronic healthcare databases, with a particular focus on signal detection methodologies. Recently finished or current projects that I am working on are: "Impact of EU risk minimisation measures on utilisation of valproates & oral retinoids in Europe", "Risk awareness and adherence with EU regulatory communication on thrombosis with thrombocytopenia syndrome and SARS-CoV-2 adenovirus vaccines", "Sapere Aude project - Hypothesis-free screening for adverse events: A new approach in drug safety research", “ISPE manuscript on quality control processes of large pharmacoepidemiologic studies using heterogenous data sources”, and "A multinational big data Covid-19 Epidemiological Study on post-infection Outcomes (ACESO)".
I have already conducted my postdoc in pharmacoepidmeiology at Utrecht University between 2021-2023, defended my PhD in ‘Pharmacoepidemiology’ at Maastricht University in 2021, finished a master course in 'Vitality and Ageing' at Leiden University in 2016, and graduated in 'General Medicine' from Tehran University of Medical Sciences in 2011.
Besides research, I teach several courses in pharmacoepidemiology, and supervise PhD, master and bachelor students at Utrecht University. I’m also an instructor and course developer at the Eu2P, the first European training programme in pharmacovigilance and pharmacoepidemiology.
Disclosure information not submitted.
Sunday, August 27, 2023
2:00 PM – 2:15 PM ADT